申请人:ELI LILLY AND COMPANY
公开号:EP0168965A1
公开(公告)日:1986-01-22
This invention provides imidazole derivatives of the formula
wherein Q is hydrogen or hydroxy and
R1 and R2 are independently F or Cl, or a pharmaceutically acceptable salt thereof.
α,α-Bis(4-chlorophenyl)-1H-imidazole-4(5)-methanol, or a pharmaceutically acceptable salt thereof, and their pharmaceutical formulations which are useful in inhibiting aromatase or treating or preventing estrogen-dependent diseases in mammals.
本发明提供了式中 Q 为氢或羟基且 R1 和 R2 独立地为 F 或 Cl 的咪唑衍生物,或其药学上可接受的盐。 α,α-双(4-氯苯基)-1H-咪唑-4(5)-甲醇,或其药学上可接受的盐,及其药物制剂,可用于抑制芳香化酶或治疗或预防哺乳动物的雌激素依赖性疾病。